Suchergebnisse
AstraZeneca's Ultomiris Meets Goal in Rare Kidney Disease Study
AstraZeneca AZN announced positive results from an interim analysis of the ongoing late-stage I CAN study, which evaluated its blockbuster rare disease drug Ultomiris (ravulizumab) for IgA
Spire to Sell Gas Storage Assets for $650M to I Squared Capital
Spire Inc. SR recently announced that it has signed an agreement to divest its natural gas storage assets in Wyoming and Oklahoma (“Spire Storage”) to I Squared Capital for $650 million. The deal is
NVIDIA Sparks April Rally in 2 Quantum Stocks, 40%+ Upside Still Left
The quantum computing sector continues to demonstrate extreme volatility in the back half of April due as much to macro forces as to technological progress. After a euphoric 2024-2025, when
Manhattan Associates (MANH) Surpasses Q1 Earnings and Revenue Estimates
Manhattan Associates (MANH) came out with quarterly earnings of $1.24 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $1.19 per share a year ago
Compared to Estimates, Manhattan Associates (MANH) Q1 Earnings: A Look at Key Metrics
Manhattan Associates (MANH) reported $282.22 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 7.4%. EPS of $1.24 for the same period compares to $1.19 a
Here's Why AngloGold Ashanti (AU) Fell More Than Broader Market
AngloGold Ashanti (AU) ended the recent trading session at $100.45, demonstrating a -5.67% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily loss
ASML: Dividende um 17% erhöht
Rekordgewinne, massive Aktienrückkäufe und eine prall gefüllte Kasse treffen auf eine historisch hohe Bewertung.…
Der Beitrag ASML: Dividende um 17% erhöht erschien zuerst auf kapitalmarktexperten.d
5 Stocks to Buy as Retail Sales Soar Amid Ongoing Geopolitical Tensions
Retail sales rose in March, surpassing expectations as the ongoing conflict with Iran saw gasoline prices climb more than 30% over the past month. Although oil prices played a major role in boosting
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
These 2 Oils and Energy Stocks Could Beat Earnings: Why They Should Be on Your Radar
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
How to Find Strong Aerospace Stocks Slated for Positive Earnings Surprises
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
If You Invested $1000 in Keysight a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and
Why American Express (AXP) is a Top Stock for the Long-Term
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
Will Asceniv Deliver for ADMA in the Upcoming Quarterly Results?
ADMA Biologics ADMA specializes in plasma-based therapies used to treat immune disorders and help prevent certain infections. Its flagship product, Asceniv, is an intravenous immunoglobulin (IVIG)
Alcoa Rebounds as Aluminum Tightens, But a Q1 Miss Tests the Rally
Global aluminum industry leader Alcoa (NYSE: AA) has served as the quintessential example of just how highly cyclical the basic materials sector can be.
So far this year, that cohort of stocks has
Astera Labs: The Tollbooth for AI's Traffic Jam
A clear message was sent on Wall Street during the third week of April, signaling a new chapter in the artificial intelligence (AI) growth story. Astera Labs, Inc. (NASDAQ: ALAB) saw its stock
How to Find Strong Retail and Wholesale Stocks Slated for Positive Earnings Surprises
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among



